Mr. Vieira joined Corcept as President of Oncology in January 2024. He brings more than 20 years of sales, marketing, and oncology experience to his role. Mr. Vieira previously served as Senior Vice President of U.S. Commercial at Mirati Therapeutics, Inc., where he built the U.S. commercial organization and led the launch of the company’s first targeted cancer therapy for the treatment of advanced non-small cell lung cancer. Prior to that, Mr. Vieira spent 15 years at Bristol-Myers Squibb in positions of increasing seniority, including Vice President of Worldwide Oncology Strategy. He also served as General Manager in Europe (The Netherlands) and was part of the leadership team that led the introduction of transformational medicines in the Immuno-Oncology space across a broad range of solid tumors. Prior to Bristol-Myers Squibb, Mr. Vieira spent 10 years at Eli Lilly and Company where he worked across manufacturing, finance, sales and marketing.

Mr. Vieira holds an MBA in Business Administration and Management from the University of Pittsburgh. He also holds a diploma in Chemical Engineering from Universidade Estadual de Campinas (UNICAMP) in São Paulo, Brazil and has completed the General Management Program at CEDEP, France.